[4-[2-(2-methylphenoxy)-5-(trifluoromethyl)anilino]-2-oxo-1-pyridinyl]methyl dihydrogen phosphate
C20H18F3N2O6P — CID 155170377
Data last refreshed: (MolForge compound catalog, from PubChem)
About [4-[2-(2-methylphenoxy)-5-(trifluoromethyl)anilino]-2-oxo-1-pyridinyl]methyl dihydrogen phosphate
[4-[2-(2-methylphenoxy)-5-(trifluoromethyl)anilino]-2-oxo-1-pyridinyl]methyl dihydrogen phosphate (PubChem CID 155170377) has the molecular formula C20H18F3N2O6P and a molecular weight of 470.34 g/mol. Its IUPAC name is [4-[2-(2-methylphenoxy)-5-(trifluoromethyl)anilino]-2-oxo-1-pyridinyl]methyl dihydrogen phosphate.
Molecular Properties
| Compound Name | [4-[2-(2-methylphenoxy)-5-(trifluoromethyl)anilino]-2-oxo-1-pyridinyl]methyl dihydrogen phosphate |
|---|---|
| PubChem CID | 155170377 |
| Molecular Formula | C20H18F3N2O6P |
| Molecular Weight | 470.34 g/mol |
| Exact Mass | 470.09 |
| IUPAC Name | [4-[2-(2-methylphenoxy)-5-(trifluoromethyl)anilino]-2-oxo-1-pyridinyl]methyl dihydrogen phosphate |
| SMILES | Cc1ccccc1Oc1ccc(C(F)(F)F)cc1Nc1ccn(COP(=O)(O)O)c(=O)c1 |
| InChI | InChI=1S/C20H18F3N2O6P/c1-13-4-2-3-5-17(13)31-18-7-6-14(20(21,22)23)10-16(18)24-15-8-9-25(19(26)11-15)12-30-32(27,28)29/h2-11,24H,12H2,1H3,(H2,27,28,29) |
| InChIKey | IKTUCRXEZSDUIC-UHFFFAOYSA-N |
| XLogP | 4.78 |
| TPSA | 110.02 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 470.34 |
| LogP ≤ 5 | 4.78 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'phosphor', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155170377 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.